Tower Research Capital LLC (Trc) Talis Biomedical Corp Transaction History

Tower Research Capital LLC (Trc)

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$0.44 - $0.54 $111 - $137	-254 Reduced 48.2%	273 $0
Q1 2023 May 09, 2023	BUY	$0.48 - $0.64 $252 - $337	527 New	527 $0
Q3 2022 Nov 10, 2022	BUY	$0.7 - $10.79 $2,944 - $45,393	4,207 New	4,207 $3,000
Q2 2022 Aug 15, 2022	SELL	$0.81 - $1.44 $12,771 - $22,704	-15,767 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$1.3 - $4.19 $13,227 - $42,633	10,175 Added 181.96%	15,767 $22,000
Q4 2021 Feb 14, 2022	SELL	$3.81 - $6.17 $29,992 - $48,570	-7,872 Reduced 58.47%	5,592 $22,000
Q3 2021 Nov 15, 2021	BUY	$6.02 - $12.46 $73,997 - $153,158	12,292 Added 1048.81%	13,464 $85,000
Q2 2021 Aug 16, 2021	SELL	$9.62 - $14.56 $79,884 - $120,906	-8,304 Reduced 87.63%	1,172 $13,000
Q1 2021 May 17, 2021	BUY	$11.2 - $27.8 $106,131 - $263,432	9,476 New	9,476 $122,000

Ticker TLIS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 26,619,200
Market Cap $47.1M
Description
Talis Biomedical Corporation operates as a molecular diagnostic company. The company is developing the Talis One system to address limitations of existing point-of-care diagnostic testing technologies for infectious diseases. It also offers Talis One COVID-19 Test System, which focuses on detection of SARS-CoV-2, the virus that causes COVID-19. ...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.